Equip Names Nikia Bergan as the Company’s First President

3 years ago

SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Equip, the leading provider of virtual, evidence-based eating disorder treatment in the…

Healthcare Leaders’ Top Priority is Addressing Burnout, According to New Survey, But Workers Are Still In Crisis

3 years ago

The US healthcare industry is in a burnout crisis: 79% of healthcare leaders and 77% of healthcare workers have been…

Curia Expands Cell Line Development Offering with CHOZN Platform

3 years ago

Curia signs license agreement with MilliporeSigma to support production of proteins and antibodiesALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) --…

Icario Names Julia Zhang Chief Technology Officer

3 years ago

Teladoc Health and Humana Veteran Will Lead the Company’s Technology, Product Development, and Data Analytics Functions Julia Zhang, Chief Technology…

Relievant Medsystems Announces Favorable Coverage Policy from Cigna Healthcare for the Intracept Procedure

3 years ago

MINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic…

AssistRx Launches Advanced Gateway to Address Increasing Demands of Patient Support Programs

3 years ago

Single API Integration Delivers Tech-first Access Solutions, Comprehensive Program Insights and Reduced Implementation TimeORLANDO, Fla., June 20, 2023 (GLOBE NEWSWIRE)…

20/20 Imaging Signs Distribution Agreement With Medovate to Bring Pioneering SAFIRA Regional Anesthesia Solution to Veterinarians

3 years ago

SONIMAGE HS2 and SAFIRA Konica Minolta’s SONIMAGE® HS2 Compact Ultrasound System and Medovate’s SAFIRA™ regional anesthesia injection technology.CRYSTAL LAKE, Ill.,…

ADvantage Therapeutics Secures Approvals for Clinical Trial of AD04™ in Alzheimer’s Disease Treatment in Poland, Bulgaria, and Slovakia

3 years ago

MIAMI, June 20, 2023 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), a pioneer in developing therapies for…

ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company’s Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens

3 years ago

YONKERS, N.Y., June 20, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery…